Dr Reddy’s Laboratories enters into Colombian market to sell cancer drugs

08 Oct 2016 Evaluate

Dr Reddy’s Laboratories has forayed into the Colombian market with its portfolio of high quality and affordable medicines for cancer drugs.

The Hyderabad-based firm operates in all major markets including the US, Russia, CIS countries and Europe with a workforce of above 20,000 employees. Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.

 

Dr. Reddys Lab Share Price

1273.50 -6.90 (-0.54%)
16-Dec-2025 10:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.50
Dr. Reddys Lab 1273.50
Cipla 1500.40
Zydus Lifesciences 923.90
Lupin 2089.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×